ESR1 and breast carcinoma: In breast cancer, studies have revealed that KDM4B not only antagonizes H3K9 tri-methylation in peripheral heterochromatin and affects H3K4/H3K9 methylation but also plays a role in estrogen receptor α-regulated breast cancer development and mammary epithelial cells proliferation [40, 41].